Welcome!

News Feed Item

FDLI to Honor Baylor-Henry, Bennett, Henteleff and Taylor

Honorees Will Receive Distinguished Service and Leadership Award at Holiday Reception December 12

WASHINGTON, Dec. 11, 2012 /PRNewswire-USNewswire/ -- The Food and Drug Law Institute will honor four outstanding food and drug law professionals with its annual Distinguished Service and Leadership Award: Minnie Baylor-Henry, Alan Bennett, Thomas O. Henteleff and John M. Taylor III.

(Logo: http://photos.prnewswire.com/prnh/20121211/DC27524LOGO)

The honorees will receive their awards at FDLI's Holiday and Leadership Awards Reception December 12 at The Westin Georgetown in Washington, D.C.

FDLI, founded in 1949, is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction. The scope of FDLI includes food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.

The award, established in 1993, is given to individuals who have a record of sustained service, leadership and contribution to the food and drug law community and/or FDLI; or provided an exceptional contribution to FDLI and/or the food and drug law community, for example, through outstanding writing or scholarship, by developing new legal theories and precedents or engaging in significant activities on behalf of the public interest.

All of this year's award recipients exemplify those criteria:

Minnie Baylor-Henry is the Worldwide Vice-President for Regulatory Affairs, Johnson & Johnson (J&J) Medical Devices & Diagnostics. As a former FDA regulator, pharmacist and regulatory leader, she has extensive leadership, regulatory and policy experience from her careers in government, as well as the pharmaceutical and consumer industries. Prior to returning to J&J, she was a National Director for Regulatory & Capital Markets Consulting at Deloitte & Touche, with a practice focus on regulatory life sciences. Prior to Deloitte & Touche, Ms. Baylor-Henry worked in several roles at J&J in the Pharmaceutical and Consumer Sectors: Senior Director for Regulatory Affairs; Vice President, U.S. Medical & Regulatory Affairs; and Global Vice President for OTC Regulatory Affairs for McNeil Consumer Healthcare. During her career at FDA, she had many roles, most notably, FDA's National Health Fraud Coordinator and the Director of the Division of Drug Marketing, Advertising, and Communications (DDMAC) from 1995-1999. As the Director of DDMAC, Ms. Baylor-Henry was responsible for the regulatory oversight of all prescription drug advertising and marketing. She currently serves as Immediate Past Chair of the Food and Drug Law Institute and President-Elect of the Drug Information Association. Ms. Baylor-Henry received her pharmacy degree from Howard University's College of Pharmacy and her law degree from Catholic University's Columbus School of Law. 

Alan Bennett, Managing Partner of the Ropes & Gray DC office, has advised clients on issues involving pharmaceutical marketing and promotion for more than 25 years. Mr. Bennett counsels clients and represents them at FDA and in Congress on many of the critical issues that affect the pharmaceutical industry. He is a recognized expert on the Hatch-Waxman Act and lifecycle management. Mr. Bennett also has extensive experience in biological products, including the new biosimilars legislation, in food additive approvals, orphan drugs, and in over the counter drugs and the procedures used to switch them from prescription to non-prescription status. He began his legal career in the Office of the General Counsel of the Food and Drug Administration, where he was a trial and appellate lawyer and legal advisor to several FDA bureaus. Subsequently he was legislative assistant to the late Senator Jacob Javits and Special Counsel to the Senate Governmental Affairs Committee, where he played a major role in one of the first medical records privacy initiatives. After leaving the Hill, Mr. Bennett co-founded a food and drug boutique firm that was ultimately known as Bennett, Turner and Coleman, which merged into Ropes & Gray in 2002. He received his law degree from Columbia University School of Law (Harlan Fiske Stone Scholar) and BA, with honors, from the University of Connecticut.

Thomas O. Henteleff joined Kleinfeld, Kaplan and Becker in 1969 after spending a year clerking for the honorable David T. Lewis of the United Court of Appeals for the 10th circuit. Mr. Henteleff became a partner of the firm 4 1/2 years after joining the firm and became the firm's managing partner in the 1990s. Since joining KK&B, Mr. Henteleff has been engaged in all aspects of "Food & Drug" law. He represents companies, trade associations, investors and individuals that manufacture, market, invest in, or otherwise have a keen interest with respect to the legal and regulatory requirements pertaining to drugs, medical devices, foods, dietary supplements, cosmetics, pesticides and other consumer products. His practice covers the administration and enforcement of the Federal Food, Drug and Cosmetic Act, the Controlled Substances Act, the Federal Trade Commission Act, the Lanham Act and other related laws. He has been honored by FDA and numerous national and international lawyer rating organizations. Mr. Henteleff has served on FDA 's Grassroots Task Force, FDLI's Advisory Board and Editorial Board, and the Advisory Board of World Pharmaceutical Report. Mr. Henteleff received his law degree from the University of California at Berkeley (Boalt Hall) and B.S., Certificate in Internal Relations, from the University of Utah (magna cum laude).

John M. Taylor III is Counselor to the Commissioner, Office of the Commissioner, FDA. In this role, he advises the Commissioner on a broad range of policy and regulatory issues. He advocates for and advances the Commissioner's priorities related to agency policies and programs. Mr. Taylor leads the development and management of FDA's emergency and crisis management policies and programs. He oversees FDA's participation in counterterrorism and emergency exercises and the coordination of the agency's emergency and crisis situations. Mr. Taylor began his FDA career in 1991 in the Office of the Chief Counsel. While at FDA, he has held several management positions such as: Senior Advisor for Regulatory Policy in the Office of the Commissioner, the Acting Director of the Office of Compliance in the Center for Drug Evaluation and Research, the Director of the Office of Enforcement, and Associate Commissioner for Regulatory Affairs. Outside of his FDA career, Mr. Taylor served as the Executive Vice President – Health for the Biotechnology Industry Organization. Until this appointment, he served as Divisional Vice President – Government Affairs, with Abbott Laboratories. Mr. Taylor received his law degree from the College of William and Mary.

SOURCE Food and Drug Law Institute

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Enterprises are adopting Kubernetes to accelerate the development and the delivery of cloud-native applications. However, sharing a Kubernetes cluster between members of the same team can be challenging. And, sharing clusters across multiple teams is even harder. Kubernetes offers several constructs to help implement segmentation and isolation. However, these primitives can be complex to understand and apply. As a result, it’s becoming common for enterprises to end up with several clusters. Thi...
In his session at 21st Cloud Expo, Carl J. Levine, Senior Technical Evangelist for NS1, will objectively discuss how DNS is used to solve Digital Transformation challenges in large SaaS applications, CDNs, AdTech platforms, and other demanding use cases. Carl J. Levine is the Senior Technical Evangelist for NS1. A veteran of the Internet Infrastructure space, he has over a decade of experience with startups, networking protocols and Internet infrastructure, combined with the unique ability to it...
"ZeroStack is a startup in Silicon Valley. We're solving a very interesting problem around bringing public cloud convenience with private cloud control for enterprises and mid-size companies," explained Kamesh Pemmaraju, VP of Product Management at ZeroStack, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"Space Monkey by Vivent Smart Home is a product that is a distributed cloud-based edge storage network. Vivent Smart Home, our parent company, is a smart home provider that places a lot of hard drives across homes in North America," explained JT Olds, Director of Engineering, and Brandon Crowfeather, Product Manager, at Vivint Smart Home, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"Codigm is based on the cloud and we are here to explore marketing opportunities in America. Our mission is to make an ecosystem of the SW environment that anyone can understand, learn, teach, and develop the SW on the cloud," explained Sung Tae Ryu, CEO of Codigm, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"Infoblox does DNS, DHCP and IP address management for not only enterprise networks but cloud networks as well. Customers are looking for a single platform that can extend not only in their private enterprise environment but private cloud, public cloud, tracking all the IP space and everything that is going on in that environment," explained Steve Salo, Principal Systems Engineer at Infoblox, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventio...
The question before companies today is not whether to become intelligent, it’s a question of how and how fast. The key is to adopt and deploy an intelligent application strategy while simultaneously preparing to scale that intelligence. In her session at 21st Cloud Expo, Sangeeta Chakraborty, Chief Customer Officer at Ayasdi, provided a tactical framework to become a truly intelligent enterprise, including how to identify the right applications for AI, how to build a Center of Excellence to oper...
"IBM is really all in on blockchain. We take a look at sort of the history of blockchain ledger technologies. It started out with bitcoin, Ethereum, and IBM evaluated these particular blockchain technologies and found they were anonymous and permissionless and that many companies were looking for permissioned blockchain," stated René Bostic, Technical VP of the IBM Cloud Unit in North America, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventi...
Gemini is Yahoo’s native and search advertising platform. To ensure the quality of a complex distributed system that spans multiple products and components and across various desktop websites and mobile app and web experiences – both Yahoo owned and operated and third-party syndication (supply), with complex interaction with more than a billion users and numerous advertisers globally (demand) – it becomes imperative to automate a set of end-to-end tests 24x7 to detect bugs and regression. In th...
High-velocity engineering teams are applying not only continuous delivery processes, but also lessons in experimentation from established leaders like Amazon, Netflix, and Facebook. These companies have made experimentation a foundation for their release processes, allowing them to try out major feature releases and redesigns within smaller groups before making them broadly available. In his session at 21st Cloud Expo, Brian Lucas, Senior Staff Engineer at Optimizely, discussed how by using ne...
Large industrial manufacturing organizations are adopting the agile principles of cloud software companies. The industrial manufacturing development process has not scaled over time. Now that design CAD teams are geographically distributed, centralizing their work is key. With large multi-gigabyte projects, outdated tools have stifled industrial team agility, time-to-market milestones, and impacted P&L stakeholders.
"Cloud Academy is an enterprise training platform for the cloud, specifically public clouds. We offer guided learning experiences on AWS, Azure, Google Cloud and all the surrounding methodologies and technologies that you need to know and your teams need to know in order to leverage the full benefits of the cloud," explained Alex Brower, VP of Marketing at Cloud Academy, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clar...
Widespread fragmentation is stalling the growth of the IIoT and making it difficult for partners to work together. The number of software platforms, apps, hardware and connectivity standards is creating paralysis among businesses that are afraid of being locked into a solution. EdgeX Foundry is unifying the community around a common IoT edge framework and an ecosystem of interoperable components.
"CA has been doing a lot of things in the area of DevOps. Now we have a complete set of tool sets in order to enable customers to go all the way from planning to development to testing down to release into the operations," explained Aruna Ravichandran, Vice President of Global Marketing and Strategy at CA Technologies, in this SYS-CON.tv interview at DevOps Summit at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"MobiDev is a software development company and we do complex, custom software development for everybody from entrepreneurs to large enterprises," explained Alan Winters, U.S. Head of Business Development at MobiDev, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.